Acupuncture Combined With Nimodipine for Prevention of Post-stroke Dementia
NCT ID: NCT06007573
Last Updated: 2023-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2021-02-01
2023-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke
NCT05731310
Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke
NCT02967484
A Clinical Trail of Integrative Medicine Approaches for Post-Stroke Cognitive Impairment
NCT04596072
the Clinical Effect of TCM Sniffing Therapy Combined With Electroacupuncture in PSCI
NCT06313866
Scalp Acupuncture for Dyskinesia After Ischemic Stroke
NCT03120650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment group
On the basis of the control group treatment, the treatment group also adopted the acupuncture treatment
The control group received oral nimodipine tablets
The control group received oral nimodipine tablets
control group
The control group received oral nimodipine tablets
The control group received oral nimodipine tablets
The control group received oral nimodipine tablets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The control group received oral nimodipine tablets
The control group received oral nimodipine tablets
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Memory or cognitive and executive dysfunction. Cognitive dysfunction will be determined after the mini mental state evaluation (MMSE) score
3. Age limited to 40-85 years, irrespective of gender
4. Stable condition, clear consciousness, no aphasia, oral medication available
5. No major comorbidity, no major depression
6. Consent and signed patient informed consent
Exclusion Criteria
2. Aphasia or hearing impairment
3. Participants in other clinical trials
4. Patients currently on medication to improve cognitive function
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Department of acupuncture and massage, Nanling Hospital of traditional Chinese Medicine, Nanling County, Wuhu City, Anhui Province
UNKNOWN
Yuzhen Pan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yuzhen Pan
DOCTOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Second Affiliated Hospital of Anhui University of Chinese Medicine
Hefei, Anhui, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-zj-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.